Doctor profile · Federal record

Dr. Nelson Kalil, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Rockville, MD

  • NPI 1427074707
  • Accepts Medicare
  • MIPS 92.1 / 100 · 2023
  • 41 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
6000 Executive Blvd Ste 620
Rockville, MD 208523876
(240) 467-5888
fax (301) 348-8983

Credentials & registration

NPPES · NUCC
NPI registered
July 2006 — 20 yrs on file
Profile last updated
April 23, 2024
Year of graduation
1985 — 41 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Maryland #D0051616
Medicaid
MD #694501500

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1427074707. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
79,226
Distinct HCPCS
10
Medicare allowed
$994,388
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 40,500 24 $1
J1449 Injection, eflapegrastim-xnst, 0.1 mg 10,972 14 $33
J0897 Injection, denosumab, 1 mg 8,581 21 $23
J1437 Injection, ferric derisomaltose, 10 mg 5,000 34 $20
J1100 Injection, dexamethasone sodium phosphate, 1 mg 4,266 31 $0
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units 4,201 19 $8
J2469 Injection, palonosetron hcl, 25 mcg 1,441 11 $1
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,025 186 $8
99214 Established patient office or other outpatient visit, 30-39 minutes 678 182 $144
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 476 36 $34

In context: peer comparison

Among 4 peers in Rockville Hematology & Oncology Physician, average services per provider: 1,992. This provider delivers 40× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$9,964
Transactions
147
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Genzyme Corporation 9 $2,843.34
E.R. Squibb & Sons, L.L.C. 9 $1,557.63
AstraZeneca Pharmaceuticals Lp 19 $971.34
Novartis Pharmaceuticals Corporation 17 $455.04
Pfizer INC. 19 $436.23
Janssen Biotech, INC. 19 $373.10
Abbvie INC. 11 $295.48
Merck Sharp & Dohme LLC 7 $184.96
Emd Serono, INC. 8 $167.34
Celgene Corporation 7 $156.74
Ipsen Biopharmaceuticals, INC 7 $155.15
Takeda Pharmaceuticals U.S.A., INC. 4 $112.37
GlaxoSmithKline, LLC. 4 $105.63
Incyte Corporation 4 $103.25
Regeneron Healthcare Solutions, INC. 3 $102.80

By nature of payment

Food and Beverage
$5,353
Consulting Fee
$4,611

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
206
Patients
42
Total drug cost
$901,697
Drug Type Claims Patients Total cost
Warfarin Sodium Generic 64 20 $1,460
Eliquis (Apixaban) Brand 62 22 $77,898
Xarelto (Rivaroxaban) Brand 29 0 $37,721
Jakafi (Ruxolitinib Phosphate) Brand 16 0 $401,486
Calquence (Acalabrutinib Maleate) Brand 12 0 $195,220
Tagrisso (Osimertinib Mesylate) Brand 12 0 $187,736
Duloxetine Hcl Generic 11 0 $176

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Nelson Kalil's medical specialty?
Dr. Nelson Kalil practices Hematology & Oncology Physician in Rockville, MD.
Where does Dr. Nelson Kalil practice?
Dr. Nelson Kalil practices at 6000 Executive Blvd Ste 620, Rockville, MD 208523876. Office phone: 2404675888.
What is Dr. Nelson Kalil's NPI?
Dr. Nelson Kalil's National Provider Identifier (NPI) is 1427074707, issued by NPPES.
Does Dr. Nelson Kalil accept Medicare assignment?
Yes. Dr. Nelson Kalil accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Nelson Kalil commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, eflapegrastim-xnst, 0.1 mg (HCPCS J1449); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.